Valeo Pharmainc (VPH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 04-2023 | 01-2023 | 10-2022 | 07-2022 | 04-2022 | |
| Sales | 13,558 | 13,162 | 12,663 | 6,073 | 4,768 |
| Cost of Goods | 9,112 | 9,433 | 11,678 | 3,845 | 3,109 |
| Gross Profit | 4,446 | 3,729 | 985 | 2,228 | 1,659 |
| Operating Expenses | 7,248 | 7,591 | 7,913 | 5,572 | 5,602 |
| Operating Income | -2,802 | -3,862 | -6,928 | -3,344 | -3,943 |
| Interest Expense | 3,333 | 3,248 | 3,096 | 1,201 | 1,198 |
| Other Income | -342 | 862 | -1,382 | -8 | 43 |
| Pre-tax Income | -6,477 | -6,248 | -11,406 | -4,553 | -5,098 |
| Net Income Continuous | -6,477 | -6,248 | -10,232 | -4,553 | -5,098 |
| Net Income | $-6,477 | $-6,248 | $-10,050 | $-4,735 | $-5,098 |
| EPS Basic Total Ops | -0.08 | -0.08 | -0.13 | -0.06 | -0.06 |
| EPS Basic Continuous Ops | -0.08 | -0.08 | -0.13 | -0.06 | -0.06 |
| EPS Diluted Total Ops | -0.08 | -0.08 | -0.13 | -0.06 | -0.06 |
| EPS Diluted Continuous Ops | -0.08 | -0.08 | -0.13 | -0.06 | -0.06 |
| EBITDA(a) | $-2,516 | $-2,383 | $-7,656 | $-3,096 | $-3,650 |